Clinical Mass Spectrometry Service Market Size, Share | 2031

Report Description

The global clinical mass spectrometry service market size is anticipated to expand at a substantial CAGR during the forecast period, between 2021 and 2028. Mass spectrometry (MS) is a precise, sensitive, and multipurpose analytical technique that is widely deployed for various applications in clinical laboratory. MS is expanding its full potential in clinical laboratories as it is extensively used to perform routine testing due to its accurate results. Significant ongoing programs are undertaken to ensure advanced automation of the technique that are compliance with regulatory requirements. The technology is extensively used for diagnostic purposes as it can identify and quantify biomolecules in a variety of biological samples in areas such as immunology, pediatrics, therapeutic drug monitoring, toxicology, endocrinology, and microbiology. MS-based assays have significant advantages in multiplexing capacity, high analytical sensitivity and specificity, and the potential for real-time in-vivo study.

Get Free Sample Report

Market Trends, Drivers, Restraints, and Opportunities:

• Significant improvements in assay performance in many areas such as endocrinology, toxicology, and biochemical genetics are key factors driving the market.
• High number of the ageing population, wide prevalence of chronic disease, and extensive use of antibiotics are expected to boost the market in the coming years.
• Increasing adoption of diagnostic automation and growing applications of MS in the clinical laboratory including clinical microbiology, chemistry, and anatomical pathology present another key aspect of the market growth.
• Factors such as high capital costs, lack of skilled employees, lack of awareness regarding the benefits of MS, and strict regulatory requirements are major challenges that can restrain the growth of the global market.
• Technological and instrumentation advancements in the development of novel clinical MS present lucrative opportunities for market growth during the forecast period.

Scope of the report:

The report on the global clinical mass spectrometry service market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Clinical Mass Spectrometry Service Market Segment Insights:

Newborn genetic & metabolic disease screening segment to hold significant market share

In the terms of service types, the clinical mass spectrometry service market is divided into newborn genetic & metabolic disease screening, vitamins & hormones, therapeutic drug testing, microbial identification, and others. The newborn genetic & metabolic disease screening segment is projected to hold significant share of the market due to rising cases of neonatal disorders. Tandem mass spectrometry as a crucial multiplex testing technique has emerged a popular technology for biochemical genetics analysis and newborn screening. On the other hand, the therapeutic drug testing segment is expected to expand at a healthy growth rate owing to increasing use of the testing for various diagnostic applications in liver disease drugs, gastroenterology & nutrition, and cancer drugs.  

Get Free Sample Report

Liquid chromatography-mass spectrometry segment to expand at a rapid pace

Based on instruments, the market is fragmented into liquid chromatography-mass spectrometry gas chromatography-mass spectrometry instrument, instrument, MALDI-TOF mass spectrometer, capillary electrophoresis mass spectrometry, and ion mobility spectrometry mass spectrometry. The liquid chromatography-mass spectrometry segment constituted significant market share in 2020 and is anticipated to expand at a rapid rate during the forecast period. The segment growth is attributed to wide use of the instrument for many clinical applications ranging from qualitative urine drug screens to quantitative, high-throughput, and analyses such as therapeutic drug monitoring. However, the gas chromatography-MS segment is expected to account for a large market share due to extensive adoption of the device for the measurement of positive urine drug screens for clinical or forensic purposes.

Hospital pharmacies segment to grow rapidly during the forecast period

Based on the end-users, the clinical mass spectrometry service market can be segregated into hospitals, health centers, and others. The hospital segment is expected to grow rapidly in the market during the forecast period due to the advancement of medical technology and increased patient traffic in hospitals. Moreover, the wide availability of the advanced technology in hospitals and rising demand for laboratory medicine are key factors boosting the segment.

Get Free Sample Report

Europe to dominate the global market

In terms of regions, the market can be categorized as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe is expected to dominate the market during the targeted period owing to the massive R&D programs and presence of the major global players manufacturing the medical instruments and devices in the region. For instance, Munich scientists from proteomics, computer science, and medicine collaborate have engaged on a large-scale project to investigate the causes of central nervous system disorders. Meanwhile, the market of North America held significant share of the market in 2020 and is anticipated to register a high CAGR during the forecast period. The regional market growth is owing to wide occurrence of various disorders such as cancer, gastroenterology, and expansion of cutting-edge analytical laboratory. Moreover, strong research component in the application of mass spectrometry to the field of liver disease is a key factor driving the regional market.

Get Free Sample Report